Crossmark

Iloprost therapy achieves good clinical and radiological short and mid-term outcomes in patients with idiopathic aseptic osteonecrosis of the knee joint also in ARCO level II

Crossref DOI link: https://doi.org/10.1007/s00402-025-06057-7

Published Online: 2025-10-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kirschbaum, Stephanie https://orcid.org/0000-0001-8263-4354
Perka, Carsten https://orcid.org/0000-0002-0993-581X
El-Kayali, Moses https://orcid.org/0000-0002-0280-1819
Gwinner, Clemens https://orcid.org/0000-0001-7489-245X
Walter-Rittel, Thula Cannon https://orcid.org/0000-0002-2003-8351
Soujon, Maurice

Donner, Stefanie https://orcid.org/0000-0001-8270-0462
Funding

Funding for this research was provided by:

Charité - Universitätsmedizin Berlin
License Information

Text and Data Mining valid from 2025-10-10

Version of Record valid from 2025-10-10
More Information

Article History

Received: 24 March 2025

Accepted: 23 August 2025

First Online: 10 October 2025

Declarations

:

: The authors declare no competing interests.

: The retrospective study design was approved by the local ethics board (EA4/251/21).

: Written consent was obtained from every study participant.

Document is current

Any future updates will be listed below